How selegiline ((-)-deprenyl) slows brain aging [[electronic resource] /] / authored by Joseph Knoll

• Record Nr.: UNINA9910785919303321
• Autore: Knoll J (József)
• Pubbl/distr/stampa: [s.l], : Bentham Science Publishers, 2012
• ISBN: 1-60805-470-5
• Descrizione fisica: 1 online resource (161 p.)
• Disciplina: 616.8527
• Soggetti: Depression, Mental; Brain - Aging; Selegiline
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and indexes.
• Nota di contenuto: Cover; Title; EUL; Contents; Foreword; Abbreviations; Keywords; Introduction; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chapter 09; Summary and Conclusion; Epilogue; References; Appendix; Author Index; Subject Index
• Sommario/riassunto: This e-book is a reference on Selegiline ((-)-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug. ((-)-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyra